Catalyst Wire Dossier Catalyst Wire Dossier

V184-005

· Themis Bioscience GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V184-005, covering 2021-10-20 to 2021-10-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005) [Phase 2]

See pricing